BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35923261)

  • 1. Utility of smear examination, culture, and serological tests in the diagnosis of visceral leishmaniasis/post-kala-azar dermal leishmaniasis at National Centre for Disease Control, Delhi.
    Singhai M; Kakkar N; Gupta N; Bala M; Singh R; Singh SK
    Trop Parasitol; 2022; 12(1):54-58. PubMed ID: 35923261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse.
    Mondal D; Ghosh P; Chowdhury R; Halleux C; Ruiz-Postigo JA; Alim A; Hossain F; Khan MAA; Nath R; Duthie MS; Kroeger A; Matlashewski G; Argaw D; Olliaro P
    Front Microbiol; 2019; 10():2268. PubMed ID: 31649631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.
    Ejazi SA; Bhattacharya P; Bakhteyar MA; Mumtaz AA; Pandey K; Das VN; Das P; Rahaman M; Goswami RP; Ali N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005035. PubMed ID: 27741241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of recombinant K39 antigen and various promastigote antigens in sero-diagnosis of visceral leishmaniasis in Bangladesh.
    Banu SS; Ahmed BN; Shamsuzzaman AKM; Lee R
    Parasite Epidemiol Control; 2016 Sep; 1(3):219-228. PubMed ID: 29988192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.
    Burza S; Sinha PK; Mahajan R; Sanz MG; Lima MA; Mitra G; Verma N; Das P
    PLoS Negl Trop Dis; 2014; 8(1):e2611. PubMed ID: 24392171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Sweat-Based Diagnosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis.
    Topno RK; Shankar V; Dikhit MR; Madhukar M; Pandey K; Das VNR; Kumar M; Kumar B; Agrawal K; Siddiqui NA; Sahoo GC; Kumar R; Singh AK; Kumar R; Singh D; Das P
    Am J Trop Med Hyg; 2018 Nov; 99(5):1162-1164. PubMed ID: 30203740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
    J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancement in Molecular Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Dixit KK; Singh R; Salotra P
    Indian J Dermatol; 2020; 65(6):465-472. PubMed ID: 33487701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of immunochromatographic dipstick test (ICT) rk39, soluble antigen ELISA and IFAT for the sero-diagnosis of visceral leishmaniasis in Morocco.
    Mniouil M; Fellah H; Amarir F; Sadak A; Et-Touys A; Bakri Y; Moustachi A; Tassou FZ; Hida M; Lyagoubi M; Adlaoui EB; Rhajaoui M; Sebti F
    Acta Trop; 2018 Jun; 182():185-189. PubMed ID: 29545149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of post kala-azar dermal leishmaniasis (PKDL) and treatment seeking behavior of PKDL patients in Nepal.
    Joshi AB; Banjara MR; Das ML; Ghale P; Pant KR; Parajuli N; Pyakurel UR; Dahal GR; Das CL; Kroeger A; Aseffa A
    PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011138. PubMed ID: 36758102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the role of the slit-skin smear in the diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Bhargava A; Ramesh V; Verma S; Salotra P; Bala M
    Indian J Dermatol Venereol Leprol; 2018; 84(6):690-695. PubMed ID: 30058565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Real-time PCR for Diagnosis of Post-Kala-azar Dermal Leishmaniasis in Endemic Foci of Bangladesh.
    Ghosh P; Hasnain MG; Hossain F; Khan MAA; Chowdhury R; Faisal K; Mural MA; Baker J; Nath R; Ghosh D; Maruf S; Shomik MS; Haque R; Matlashewski G; Hamano S; Duthie MS; Mondal D
    Open Forum Infect Dis; 2018 Oct; 5(10):ofy234. PubMed ID: 30320150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-kala-azar dermal leishmaniasis with mucosal involvement: an unusual case presentation including successful treatment with miltefosine.
    Salam MA; Siddiqui MA; Nabi SG; Bhaskar KR; Mondal D
    J Health Popul Nutr; 2013 Jun; 31(2):294-7. PubMed ID: 23930349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
    Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis.
    Dixit KK; Ramesh V; Upadhyay S; Singh AK; Singh OP; Sundar S; Singh R; Salotra P
    J Clin Microbiol; 2021 Aug; 59(9):e0013221. PubMed ID: 34160275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
    Kumar A; Singh VK; Tiwari R; Madhukar P; Rajneesh ; Kumar S; Gautam V; Engwerda C; Sundar S; Kumar R
    Front Immunol; 2023; 14():1236952. PubMed ID: 37638047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
    Zijlstra EE
    Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.